Levothyroxine Sodium (Par Pharmaceutical Companies, Inc.)


Welcome to the PulseAid listing for the Levothyroxine Sodium drug offered from Par Pharmaceutical Companies, Inc.. This l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical Companies, Inc.
NON-PROPRIETARY NAME: Levothyroxine Sodium Anhydrous
SUBSTANCE NAME: LEVOTHYROXINE SODIUM ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-12-11
END MARKETING DATE: 0000-00-00


Levothyroxine Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLevothyroxine Sodium from Par Pharmaceutical Companies, Inc.
LABELER NAME: Par Pharmaceutical Companies, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200(ug/5mL)
START MARKETING DATE: 2015-12-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42023-161_7ebde671-a1ae-4b52-9307-f453fb0233c6
PRODUCT NDC: 42023-161
APPLICATION NUMBER: ANDA205366

Other LEVOTHYROXINE SODIUM ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions, Inc.Levothyroxine Sodium
Fresenius Kabi USA, LLCLevothyroxine Sodium
Par Pharmaceutical Companies, Inc.Levothyroxine Sodium
Par Pharmaceutical Inc.Levothyroxine Sodium
Unit Dose ServicesLevothyroxine Sodium